WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of NCI, Inc. (“NCIT” or the “Company”) (NASDAQ: NCIT) in connection with the proposed acquisition of the Company by private funds managed by an affiliate of H.I.G. Capital, LLC. Under the terms of the acquisition agreement, the Company’s shareholders will receive $20.00 in cash for each NCIT Class A and Class B share they own.
WeissLaw is investigating whether NCIT’s Board acted to maximize shareholder value prior to entering into the agreement. Notably, the offer price is $6.00 less than the analyst target price of $26.00, and $1.40 less the Company’s 52-week high of $21.40. Additionally, NCIT recently announced that its first quarter 2017 revenue “exceed the midpoint of management’s guidance range . . . by at least $2 million,” representing growth of 2% sequentially. In its first quarter 2017 earnings call, NCIT’s CEO expressed confidence in the Company’s profitability metrics, which he explained “continue to be strong both sequentially and year-over-year.” Finally on June 5, 2017, NCIT issued a press release announcing that it had been awarded a very lucrative position in a multi-billion contract with the U.S. Army.
Given these facts, WeissLaw is investigating whether NCIT’s Board acted in the best interests of its public shareholders to maximize shareholder value prior to entering into the agreement. If you own NCIT shares and would like more information about your rights or our investigation, or if you have information to share with us, please contact Joshua Rubin by telephone at (888) 593-4771 or by email at firstname.lastname@example.org.
WeissLaw LLP has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties. We have recovered over a billion dollars for defrauded clients and obtained important corporate governance relief in many of these cases. If you have information or would like legal advice concerning possible corporate wrongdoing (including insider trading, waste of corporate assets, accounting fraud, or materially misleading information), consumer fraud (including false advertising, defective products, or other deceptive business practices), or anti-trust violations, please email us at email@example.com or fill out the form on our website, http://www.weisslawllp.com/nci-inc/